• Vol. 31 No. 4, 497–501
  • 15 July 2002

Fluconazole Susceptibility of Candida Species in Singapore by Disc Diffusion Test



Introduction: Resistance of Candida species to fluconazole has been increasingly reported worldwide. To date, the prevalence of resistance to fluconazole in Singapore is unknown. The aim of this study was to use a newly described agar disc diffusion method to study levels of susceptibility of Candida species to fluconazole in several hospitals in Singapore.

Materials and Methods: Three hundred and ninety Candida isolates from clinical specimens collected from different sites were tested, of which 191 isolates (49.0%) were C. albicans, 69 (17.7%) were C. parapsilosis, 59 (15.1%) were C. glabrata, 51 (13.1%) were C. tropicalis and 4 (1.0%) were C. krusei. Susceptibility testing was performed using 25 μg fluconazole discs and standard Mueller-Hinton agar supplemented with 2% glucose and 0.5 μg/mL of methylene blue.

Results: Overall, 381 (97.7%) isolates were susceptible, 6 (1.5%) were susceptible dose-dependent, and 3 (0.8%) were resistant to fluconazole. Of the individual species, 99.5% of C. albicans, 93.2% of C. glabrata, 0% of C. krusei, and 100% of C. parapsilosis, C. tropicalis and other Candida species were susceptible.

Conclusion: The resistance of Candida species to fluconazole, as measured using a new disc diffusion method, is low in Singapore, with the exception of C. krusei. Fluconazole remains a useful agent for the treatment of candidiasis in this country.

Candida species is becoming increasingly important as a cause of serious infections particularly in immunocompromised patients. Surveillance in the USA between April 1995 and June 1996 revealed that Candida was the fourth leading cause of nosocomial bloodstream infections, accounting for 8% of such infections.

This article is available only as a PDF. Please click on “Download PDF” on top to view the full article.